Hourglass Capital, LLC Merck & Co., Inc. Transaction History

Hourglass Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $438,179 - $481,887	-6,113 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $46,937 - $52,091	-654 Reduced 9.66%	6,113 $500,000
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $12,920 - $15,094	-185 Reduced 2.66%	6,767 $567,000
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $6,958 - $7,936	-100 Reduced 1.42%	6,952 $578,000
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $22,442 - $26,044	-344 Reduced 4.65%	7,052 $539,000

Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $433,923 - $466,909	7,396	7,396 $474,000

3,770

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hourglass Capital, LLC with notifications on news.